The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension.

CONCLUSION: The combination of OLM/AML was superior to PER/AML in reducing CSBP and other efficacy measures, including a significantly higher rate of BP normalization. PMID: 24293132 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24293132?dopt=Abstract

Source: Advances in Therapy - November 30, 2013 Category: Drugs & Pharmacology Authors: Ruilope L, Schaefer A Tags: Adv Ther Source Type: research